Novartis
(NYSE) NVS
Novartis Financials at a Glance
Market Cap
$282.58B
Revenue (TTM)
$56.15B
Net Income (TTM)
$13.98B
EPS (TTM)
$7.19
P/E Ratio
20.47
Dividend
$4.74
Beta (Volatility)
0.33 (Low)
Dividend
$4.74
Beta (Volatility)
0.33 (Low)
Price
$148.51
Volume
1,147,468.28
Open
$146.56
Price
$148.51
Volume
1,147,468.28
Open
$146.56
Previous Close
$148.61
Daily Range
$146.22 - $148.98
52-Week Range
$97.72 - $170.46
Dividend
$4.74
Beta (Volatility)
0.33 (Low)
Price
$148.51
Volume
1,147,468.28
Open
$146.56
Previous Close
$148.61
Daily Range
$146.22 - $148.98
52-Week Range
$97.72 - $170.46
NVS News
NVS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Novartis
Industry
Pharmaceuticals
Sector
Health CareEmployees
75,267
CEO
Vasant Narasimhan, MD
Website
www.novartis.comHeadquarters
Basel, 4056, CH
NVS Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
31%
Net Income Margin
25%
Return on Equity
31%
Return on Capital
20%
Return on Assets
12%
Earnings Yield
4.89%
Dividend Yield
0.03%
Payout Ratio
53.54%
Stock Overview
Market Cap
$282.58B
Shares Outstanding
1.91B
Volume
1.15M
Short Interest
0.00%
Avg. Volume
2.29M
Financials (TTM)
Gross Profit
$41.12B
Operating Income
$17.07B
EBITDA
$22.99B
Operating Cash Flow
$19.24B
Capital Expenditure
$1.56B
Free Cash Flow
$17.69B
Cash & ST Invst.
$11.59B
Total Debt
$37.03B
Novartis Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.33B
-1.6%
Gross Profit
$9.79B
-4.3%
Gross Margin
73.44%
N/A
Market Cap
$282.58B
N/A
Market Cap/Employee
$3.72M
N/A
Employees
75,883
N/A
Net Income
$2.41B
-14.5%
EBITDA
$5.07B
-2.2%
Quarterly Fundamentals
Net Cash
$25.52B
-42.5%
Accounts Receivable
$10.93B
+33.2%
Inventory
$6.27B
+9.5%
Long Term Debt
$31.25B
+36.3%
Short Term Debt
$5.78B
-30.5%
Return on Assets
12.13%
N/A
Return on Invested Capital
19.92%
N/A
Free Cash Flow
$1.64B
-46.3%
Operating Cash Flow
$2.25B
-46.3%